首页|期刊导航|Oncology Research|Regulation of theWnt/β-Catenin Signaling Pathway by Non-Coding RNAs in Esophageal Squamous Cell Carcinoma:Mechanisms,Translational Relevance,and Therapeutic Implications

Regulation of theWnt/β-Catenin Signaling Pathway by Non-Coding RNAs in Esophageal Squamous Cell Carcinoma:Mechanisms,Translational Relevance,and Therapeutic ImplicationsOA

中文摘要

Esophageal Squamous Cell Carcinoma(ESCC)is a highly aggressive malignancy characterized by a poor long-term prognosis.Aberrant activation of the canonicalWnt/β-catenin pathway serves as a central oncogenic driver in ESCC,with large-scale genomic analyses revealing that most patients harbor alterations in pathway-associated genes.This signaling axis orchestrates a wide array of malignant phenotypes,including tumor proliferation,invasion,epithelial-mesenchymal transition(EMT),cancer stemness,and therapeutic resistance.Therefore,this review aims to provide a comprehensive synthesis of the multifaceted crosstalk between various ncRNA classes and theWnt/β-catenin axis,highlighting their roles in ESCC progression and their potential as mechanism-based clinical tools.Emerging evidence identifies non-coding RNAs(ncRNAs)—including microRNAs(miRNAs),long non-coding RNAs(lncRNAs),and circular RNAs(circRNAs)—as key regulators of this pathway in ESCC.In this article,we systematically summarize the molecular mechanisms by which 36 unique ncRNA species(20 miRNAs,10 lncRNAs,and 6 circRNAs)modulate Wnt signaling.Oncogenic ncRNAs promote malignant progression by suppressing negative regulators within complex competing endogenous RNA(ceRNA)networks,whereas tumor-suppressive ncRNAs inhibit pathway activation by targeting Wnt ligands,receptors,or downstream effectors.Furthermore,we discuss the translational relevance of ncRNA-based biomarkers for risk stratification and prognosis in clinical cohorts.Finally,we evaluate pharmacological strategies for ncRNA-based therapeutics while highlighting critical challenges related to delivery efficiency,specificity,molecular stability,off-target effects,tumor heterogeneity,and clinical validation.Ultimately,a clearer understanding of the ncRNA-Wnt regulatory network is essential for developing personalized,mechanism-based diagnostic and therapeutic strategies.

Chao Han;Ming Hou;Ruifeng Yang;Xiaoping Wei;Cheng Wang

Department of Thoracic Surgery,The Second Hospital&Second Clinical Medical College,Lanzhou University,Lanzhou,ChinaDepartment of Thoracic Surgery,The Second Hospital&Second Clinical Medical College,Lanzhou University,Lanzhou,ChinaDepartment of Thoracic Surgery,The Second Hospital&Second Clinical Medical College,Lanzhou University,Lanzhou,ChinaDepartment of Thoracic Surgery,The Second Hospital&Second Clinical Medical College,Lanzhou University,Lanzhou,ChinaDepartment of Thoracic Surgery,The Second Hospital&Second Clinical Medical College,Lanzhou University,Lanzhou,China

医药卫生

Esophageal squamous cell carcinoma(ESCC)Wnt/β-catenin signaling pathwaynon-coding RNAepithelial-mesenchymal transition(EMT)chemoresistance

《Oncology Research》 2026 (9)

P.203-222,20

supported by:Gansu Provincial Natural Science Foundation Project(21JR11RA131)The Lanzhou Science and Technology Plan Program(Grant No.2023-2-41).

10.32604/or.2026.081222

评论